SLC12A5 and epilepsy: In particular, a down-regulation of KCC2 may play a key role in the pathogenesis of epilepsy, neuropathic pain, and spasticity (Cohen et al., 2002; Coull et al., 2003; De Koninck, 2007; Doyon et al., 2013; Kaila et al., 2014).